InvestorsHub Logo
Followers 33
Posts 2840
Boards Moderated 2
Alias Born 10/24/2015

Re: Awl416 post# 13

Sunday, 03/17/2024 7:30:11 PM

Sunday, March 17, 2024 7:30:11 PM

Post# of 43
The pilot trial is to begin in mainland China with the first patient expected to be enrolled in 1H. Potential to expand into Hong Kong, Macao, and Taiwan, with Senti retaining all commercialisation rights outside of those regions and mainland China. Up to $156 million in development milestones and potential
tiered royalties post-commercialisation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNTI News